Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The progression of chronic myelogenous leukemia (CML) to blast crisis is supported by self-renewing leukemic stem cells. In normal mouse hematopoietic stem cells, the process of self-renewal involves the beta-catenin-signaling pathway. We investigated whether leukemic stem cells in CML also use the beta-catenin pathway for self-renewal. METHODS: We used fluorescence-activated cell sorting to isolate hematopoietic stem cells, common myeloid progenitors, granulocyte-macrophage progenitors, and megakaryocyte-erythroid progenitors from marrow during several phases of CML and from normal marrow. BCR-ABL, beta-catenin, and LEF-1 transcripts were compared by means of a quantitative reverse-transcriptase-polymerase-chain-reaction assay in normal and CML hematopoietic stem cells and granulocyte-macrophage progenitors. Confocal fluorescence microscopy and a lymphoid enhancer factor/T-cell factor reporter assay were used to detect nuclear beta-catenin in these cells. In vitro replating assays were used to identify self-renewing cells as candidate leukemic stem cells, and the dependence of self-renewal on beta-catenin activation was tested by lentiviral transduction of hematopoietic progenitors with axin, an inhibitor of the beta-catenin pathway. RESULTS: The granulocyte-macrophage progenitor pool from patients with CML in blast crisis and imatinib-resistant CML was expanded, expressed BCR-ABL, and had elevated levels of nuclear beta-catenin as compared with the levels in progenitors from normal marrow. Unlike normal granulocyte-macrophage progenitors, CML granulocyte-macrophage progenitors formed self-renewing, replatable myeloid colonies, and in vitro self-renewal capacity was reduced by enforced expression of axin. CONCLUSIONS: Activation of beta-catenin in CML granulocyte-macrophage progenitors appears to enhance the self-renewal activity and leukemic potential of these cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both myelodysplastic syndrome (Pang et al., 2013) and acute and chronic myelogenous leukemias begin with nonlethal mutations in the HSC pool, often leading to successful expansion of mutant HSC clones at the expense of normal HSC, and which progress eventually to leukemia (Corces-Zimmerman et al., 2014; Jamieson et al., 2004; Jan et al., 2012)”
From Quiescent Hematopoietic Stem Cells Accumulate DNA Damage during Aging that Is Repaired upon Entry into Cell Cycle (2014) · cites this paper as Jamieson et al., 2004
In the citing paper
“Although CML is considered a HSC-initiated disease, studies indicate that granulocyte-monocyte progenitors isolated from advanced-phase CML patients reacquire self-renewal properties and therefore may also serve as LSC.6”
From Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo (2010) · cites this paper as [6]
In the citing paper
“Although CML is considered a HSC-initiated disease, studies indicate that granulocyte-monocyte progenitors isolated from advanced-phase CML patients reacquire self-renewal properties and therefore may also serve as LSC.6”
From Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo (2010) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Self-citationConstitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
Self-citationA minute chromosome in human chronic granulocytic leukemia
Nowell̀, P. C. (1960) · Science · Cited by 2,269
Wnt proteins are lipid-modified and can act as stem cell growth factors
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., & Nusse, R. (2003) · Nature · doi:10.1038/nature01611 · Cited by 2,257
Self-citationA role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Self-citation
Cited by
Items 901–1,000 of 1,000
Horne, G. A., & Copland, M. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1303477 · Cited by 15
“Its activation has been demonstrated in acute disease, namely AML LSCs and within myeloid BC CML [29,78].”
BackgroundAlterations in WNT Signaling in Leukemias
Fetisov, T. I., Lesovaya, E. A., Геннадиевна, Я. М., Игоревич, К. К., & Belitsky, G. A. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918120039 · Cited by 16
Discovery of chemical probes that suppress Wnt/β‐catenin signaling through high‐throughput screening
Yamaguchi, K., Nagatoishi, S., Tsumoto, K., & Furukawa, Y. (2020) · Cancer Science · doi:10.1111/cas.14297 · Cited by 15
B-Lymphoid Blast Phase–Chronic Myeloid Leukemia: Current Therapeutics
Yohannan, B., & George, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911836 · Cited by 24
“Pre-B-cell is the cell of origin in Ph(+) B-cell ALL, whereas granulocyte-macrophage progenitor is the cell of origin in blast phase CML [8].”
BackgroundIvanov, D., Feenstra, J. D. M., Sadovnik, I., Herrmann, H., Peter, B., Willmann, M., Greiner, G., Slavnitsch, K., Hadzijusufovic, E., Rülicke, T., et al. (2023) · American Journal of Hematology · doi:10.1002/ajh.26889 · Cited by 16
Composition and characteristics of distinct macrophage subpopulations in the mouse thymus
LIU, L.-T., Lang, Z., Li, Y., Zhu, Y., ZHANG, J.-T., Guo, S.-F., Wang, J.-X., Wang, H., & XU, Y.-D. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1448 · Cited by 14
Suppression of autophagy by BCR/ABL
Calabretta, B., & Salomoni, P. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/278 · Cited by 14
Zhang, W., Li, Y., Yang, L., Zhou, B., Chen, K., Meng, W., Liu, Y., Hu, J., Sun, X., & Zhou, Z. (2012) · Clinical and Experimental Medicine · doi:10.1007/s10238-012-0212-7 · Cited by 14
p53: The Barrier or Guardian for Cell Dedifferentiation?
Pan, Y., Cai, S., Fu, X., & Andong, Z. (2014) · BioScience · doi:10.1093/biosci/biu133 · Cited by 14
Molecular pathogenesis of tyrosine kinase resistance in chronic myeloid leukemia
Rosée, P. G. L., & Hochhaus, A. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283366be1 · Cited by 14
Optimized Treatment Schedules for Chronic Myeloid Leukemia
He, Q., Zhu, J., Dingli, D., Foo, J., & Leder, K. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005129 · Cited by 14
“This is further supported by the observation that blast crisis emerges due the acquisition of additional mutations in CML progenitor cells (not stem cells) [3].”
Ma, W., Liu, F., Yuan, L., Zhao, C., & Chen, C. (2019) · Oncology Reports · doi:10.3892/or.2019.7408 · Cited by 17
“BCR‐ABL fusion gene regulates β-catenin, and it may be associated with the high expression of β-catenin observed in CML (25).”
BackgroundScreening and identification of proteins interacting with nucleostemin
Yang, H., Jin, G., Meng, L., Zhang, J., Liu, W.-B., & Shou, C.-C. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i31.4812 · Cited by 16
Wang, C., Mao, F., Zhang, M., Li, W., Guan, H., Sun, Y., Xie, S., & Zhong, X. (2013) · Neuropathology · doi:10.1111/neup.12041 · Cited by 14
“In addition, activation of the b-catenin pathway has been detected in chronic myeloid leukemia.(19) Considering the correlation of DJ-1 and b-catenin with PTEN/Akt, the involvement of DJ-1 and b-catenin in gliomas should be clarified.”
BackgroundKosugi, N., Ebihara, Y., Nakahata, T., Saisho, H., Asano, S., & Tojo, A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.505.11.2 · Cited by 14
Stem Cell Biomarkers in Chronic Myeloid Leukemia
Jiang, X., Zhao, Y. S., Forrest, D. L., Smith, C. A., Eaves, A. C., & Eaves, C. J. (2008) · Disease Markers · doi:10.1155/2008/146871 · Cited by 14
Defining 'stemness': Notch and Wnt join forces?
Jacobsen, S. E. W. (2005) · Nature Immunology · doi:10.1038/ni0305-234 · Cited by 15
Mixed Lineage Leukemia Translocations and a Leukemia Stem Cell Program
Faber, J., & Armstrong, S. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0972 · Cited by 15
“First evidence for the acquisition of stem cell– like properties in human committed progenitors was provided by a recent report assessing CML blast crisis where cells with a phenotype similar to GMP were identified as LSC candidates and transcriptional targets of h-catenin as potential mediators of selfrenewal (5).”
BackgroundRole of Cancer Stem Cells in Cancer Biology and Therapy
(2013) · CRC Press eBooks · doi:10.1201/b15734 · Cited by 14
Modeling glioma intratumoral heterogeneity with primary human neural stem and progenitor cells
Liu, D. D., Liu, D. D., Eastman, A. E., Womack, N. L., Ohene-Gambill, B. F., Baez, M., & Weissman, I. L. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102597 · Cited by 15
Heterocyclic Compounds and their Derivatives with Potential Anticancer Activity
Kaur, A. P., Shakya, A. K., Singh, R., Badhwar, R., & Sawhney, S. K. (2024) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.58.1s.3 · Cited by 19
An Overview of Myeloid Blast-Phase Chronic Myeloid Leukemia
Pamuk, G. E., & Ehrlich, L. A. (2024) · Cancers · doi:10.3390/cancers16213615 · Cited by 20
“The activation of the β -catenin pathway in CML granulocyte–macrophage progenitors was interpreted as an enhancement in self-renewal activity and the leukemic potential of the cells [111].”
BackgroundAdvances in RNA editing in hematopoiesis and associated malignancies
Pu, S., Cheng, T., & Cheng, H. (2025) · Blood · doi:10.1182/blood.2024027379 · Cited by 14
Steinert, G., Oancea, C., Roos, J., Hagemeyer, H., Maier, T. J., Ruthardt, M., & Puccetti, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022540 · Cited by 13
Stem Cell Competition for Niche Occupancy: Emerging Themes and Mechanisms
Zhao, R., & Xi, R. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9128-3 · Cited by 13
“Actually, increasing evidence indicate that cancer stem cell may account for the initiation of many types of tumors and cancers of clone origin [41, 42], and normal HSCs are efficiently outcompeted by leukemia stem cells with different cellular changes in HSCderived leukemia malignancies, such as myelodysplastic syndr…”
BackgroundWnt3a expression is associated with poor prognosis of esophageal squamous cell carcinoma
Oguma, J., Ozawa, S., Kazuno, A., Nitta, M., Ninomiya, Y., & Kajiwara, H. (2017) · Oncology Letters · doi:10.3892/ol.2017.7666 · Cited by 13
Knocking the Wnt out of the Sails of Leukemia Stem Cell Development
Deshpande, A. J., & Buske, C. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.11.006 · Cited by 14
“Furthermore, it was previously demonstrated that the acquisition of self-renewal by bcatenin activation in myeloid progenitors seems to be a crucial event in the evolution of chronic phase CML to blast crisis CML (Jamieson et al., 2004).”
BackgroundThe allometry of chronic myeloid leukemia
Pacheco, J. M., Traulsen, A., & Dingli, D. (2009) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2009.04.003 · Cited by 13
“HSC pool is not expanded (Jamieson et al., 2004; Udomsakdi et al., 1992) and BCR-ABL expression does not give a fitness advantage to the LSC compared to HSC (Huntly et al.”
BackgroundThe role of aberrant transcription factor in the progression of chronic myeloid leukemia
Zhang, S. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190802163305 · Cited by 15
“self-renewal ability as compared with the levels in progenitors from normal marrow [10], which is coincided with the role of gain-of-function mutation of GATA-2 in CML blast crisis.”
BackgroundMoradi, F., Babashah, S., Sadeghizadeh, M., Jalili, A., Hajifathali, A., & Roshandel, H. (2019) · PubMed Central · doi:10.22038/ijbms.2019.31879.7666 · Cited by 17
“The signaling pathways like Hedgehog (Hh) (26, 27), Wnt/β-catenin (28), Notch (25), Alox5 (30, 31), Foxo (65-67), and Ras (62) may play roles in differentiation and survival of LSCs (35, 36).”
BackgroundLim, W., Choi, H., Kim, J., Kim, S., Jeon, S., Kou, N., Song, S.-Y., Oh, H.-K., Im, Y.-G., Lee, G. C., et al. (2014) · Journal of Molecular Histology · doi:10.1007/s10735-014-9584-1 · Cited by 13
Metastasis of Colorectal Cancer
Beauchemin, N., & Huot, J. (2010) · Cancer metastasis · doi:10.1007/978-90-481-8833-8 · Cited by 17
Polycomb segment myeloid malignancies
Saunthararajah, Y., & Maciejewski, J. (2012) · Blood · doi:10.1182/blood-2011-12-391268 · Cited by 12
Genetically engineered mouse models of human B-cell precursor leukemias
Hauer, J., Borkhardt, A., Sánchez-García, I., & Cobaleda, C. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949137 · Cited by 18
“One clear example can be found in chronic myelogenous leukemia, in which the translocation creating the BCRABLp210 oncogene appears and exerts its first oncogenic effects in HSCs, in spite of the fact that the disease is characterized by the accumulation of differentiated granulocytic cells.(104) An additional aspect…”
BackgroundSirtuins, Tissue Maintenance, and Tumorigenesis
Mohrin, M., & Chen, D. (2013) · Genes & Cancer · doi:10.1177/1947601912474930 · Cited by 12
Modeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft Models
Sontakke, P., Jaques, J., Vellenga, E., & Schuringa, J. J. (2016) · Stem Cells International · doi:10.1155/2016/1625015 · Cited by 17
The Involvement of Oxidative Stress in Chronic Myeloid Leukemia
Pascu, E. G., Găman, M., Moisă, C., ASSANI, A. D., & Găman, A. M. (2020) · ROMANIAN BIOTECHNOLOGICAL LETTERS · doi:10.25083/rbl/25.1/1267.1274 · Cited by 14
Repurposing of Anticancer Stem Cell Drugs in Brain Tumors
Bahmad, H. F., Daher, D., Aljamal, A. A., Elajami, M. K., Oh, K. S., Moreno, J. C. A., Delgado, R. G., Suarez, R., Zaldivar, A., Azimi, R., et al. (2021) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554211025482 · Cited by 12
Shedding Light on Targeting Chronic Myeloid Leukemia Stem Cells
Houshmand, M., Kazemi, A., Anjam-Najmedini, A., Ali, M. S., Gaidano, V., Cignetti, A., Fava, C., Cilloni, D., Saglio, G. N., & Circosta, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245805 · Cited by 17
“Furthermore, expression of β-catenin increases with CML progression and is responsible for the increased self-renewal of CML progenitors in blast crisis [5].”
BackgroundMajeti, R., Jamieson, C. H. M., Pang, W. W., Jaiswal, S., Leeper, N. J., Wernig, G., & Weissman, I. L. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042420-104436 · Cited by 13
Wu, A., Yen, R., Grasedieck, S., Lin, H., Nakamoto, H., Forrest, D. L., Eaves, C. J., & Jiang, X. (2023) · Leukemia · doi:10.1038/s41375-023-02062-0 · Cited by 13
Irvine, D. A., Heaney, N. B., & Holyoake, T. L. (2009) · Blood Reviews · doi:10.1016/j.blre.2009.11.002 · Cited by 16
Alternative Splicing in Chronic Myeloid Leukemia (CML): A Novel Therapeutic Target?
Adamia, S., Pilarski, P. M., Bar‐Natan, M., Stone, R. M., & Griffin, J. D. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113139990083 · Cited by 13
Perrotti, D., & Harb, J. G. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.546914 · Cited by 12
Prostate cancer stem cell therapy: hype or hope?
Masters, J. R., Kane, C., Yamamoto, H., & Ahmed, A. (2008) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2008.22 · Cited by 12
“In consequence, it is possible that some downstream cells will acquire stem cell properties and become responsible for the progression of the cancer, leaving the initiating cells behind, and, perhaps irrelevant, as it appears to happen in CML”
BackgroundWang, Z., Chen, C., & Chen, W. (2015) · Stem Cells · doi:10.1002/stem.2218 · Cited by 13
N‐Cadherin Aided in Maintaining the Characteristics of Leukemic Stem Cells
Zhi, L., Gao, Y., Yu, C., Zhang, Y., Zhang, B., Yang, J., & Yao, Z. (2016) · The Anatomical Record · doi:10.1002/ar.23345 · Cited by 12
“…of HSCs as well as reduces differentiation. b-Catenin activation has been proposed to be a common pathway shared by different cancer stem cells (Jamieson et al., 2004; Mikesch et al., 2007). b-Catenin is associated with drug resistance of chronic myeloid leukemia and aggression of CD341 cancer…”
BackgroundLaranjeira, A. B. A., & Yang, S. X. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1236785 · Cited by 14
Advances in Cancer Stem Cell Biology
Scatena, R., Giardina, B., & Mordente, A. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0809-3 · Cited by 14
Ando, S., Abe, R., Sasaki, M., Murata, J., Inokuma, D., & Shimizu, H. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080362 · Cited by 14
Heinrichs, S., Berman, J. N., Ortiz, T. M., Kornblau, S. M., Neuberg, D. S., Estey, E. H., & Look, A. T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05555.x · Cited by 14
“Although recent studies indicate that the transformed self-renewing leukaemic progenitor in a subset of AML cases has phenotypic properties of a granuloctye–monocyte progenitor (GMP) (Jamieson et al, 2004), the trilineage dysplasia that characterises MDS and AMLs arising from MDS indicates that the LSC in MDS reside i…”
BackgroundFranco, S. D., Mancuso, P., Benfante, A., Spina, M., Iovino, F., Dieli, F., Stassi, G., & Todaro, M. (2011) · Cancers · doi:10.3390/cancers3021957 · Cited by 15
“Jamieson and colleagues [46] first identified the aberrant Wnt/βcatenin self renewal pathway activation in leukemic stem cell propagation; Wnt pathway has been later considered important also in breast cancer stem cells (BCSCs).”
BackgroundMonitoring of leukemia stem cells in chronic myeloid leukemia patients
Cui, J., Zhu, Z., Liu, S., Li, Q., Li, M., Cheng, H. W., Zhong, Z., Li, W., You, Y., Zhu, X., et al. (2018) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1421755 · Cited by 12
“[8] had also revealed that CML patients had higher levels of progenitor pool (CD34þ Lin cells) in bone marrow than normal patients, while the population of hematopoietic stem cells (CD34þ CD38 CD90þ Lin ) within the progenitor pool did not expand significantly with disease progression.”
Hematopoietic Stem Cells and Their Niche
Iwasaki, H., & Suda, T. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-347-3_2 · Cited by 16
“The Wnt/b-catenin signal, a causative pathway for self-renew, differentiation, and proliferation, is enhanced in the mutated nucleus of granulocyte-macrophage progenitors in the CML patient, due to the higher concentration of the b-catenin and irregularly activated TCF/LEF (T-cell factor/lymphocyte-enhancement factor)…”
BackgroundBirdwell, C. E., Fiskus, W. C., Kadia, T. M., Mill, C. P., Sasaki, K., Daver, N. G., Dinardo, C. D., Pemmaraju, N., Borthakur, G. M., Davis, J. A., et al. (2023) · Leukemia · doi:10.1038/s41375-023-02108-3 · Cited by 13
Nguyen, L. T., Zimmermann, K., Kowenz‐Leutz, E., Lim, R., Hofstätter, M., Mildner, A., & Leutz, A. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.11.011 · Cited by 11
Guo, Q., Qiu, P., Pan, K., Liang, H., Liu, Z., & Lin, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-72406-y · Cited by 11
“It has been shown in several studies that CSCs may arise from mutations in normal stem cells yet may also be derived from mutant progenitor cells and be highly heterogeneous 44–47 .”
Oncogenesis and cancer stem cells: current opinions and future directions
Cheng, X., & O'Neill, H. C. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00664.x · Cited by 15
Pehli̇van, M., Çalışkan, C., Yüce, Z., & Sercan, H. O. (2017) · Tumor Biology · doi:10.1177/1010428317701654 · Cited by 11
Tortorella, S. M., Hung, A., & Karagiannis, T. C. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6096 · Cited by 12
“Elevated levels of nuclear b -catenin were detected in the granulocyte-macrophage progenitor pool from patients with blast-phase CML and imatinib-resistant CML compared with marrow collected from healthy individuals (161).”
Wnt Signaling in Leukemias and Myeloma: T-Cell Factors are in Control
Tiemessen, M. M., & Staal, F. J. T. (2013) · Future Oncology · doi:10.2217/fon.13.122 · Cited by 13
Kittrell, F. S., Carletti, M. Z., Kerbawy, S., Heestand, J., Xian, W., Zhang, M., LaMarca, H. L., Sonnenberg, A., Rosen, J. M., Medina, D., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2863 · Cited by 11
“A role for stem cells or distinct progenitor cells as the cells of origin in many types of cancer has been proposed [ 29-32 ].”
BackgroundJärås, M., Johnels, P., Ågerstam, H., Lassen, C., Rissler, M., Edén, P., Cammenga, J., Olofsson, T., Bjerrum, O. W., Richter, J., et al. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2008.11.003 · Cited by 12
“However, despite the increased number of myeloid cells at different maturation stages observed in CML patients, there has been recent evidence of expansion of megakarocyte and erythroid progenitor cells in the chronic-phase of CML [14,15], which is in line with the finding that CML progenitor cells form EPO-independen…”
ResultThe one-two punch: Combination treatment in chronic myeloid leukemia
Sweet, K. L., Hazlehurst, L., & Pinilla-Ibarz, J. A. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.07.017 · Cited by 11
“[77] Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder”
BackgroundInfluentialMouse models as tools to understand and study BCR-ABL1 diseases.
Koschmieder, S., & Schemionek, M. (2011) · PubMed · Cited by 12
Association between prognostic survival of human colorectal carcinoma and ZNRF3 expression
Yu, N., Zhu, H., Tao, Y., Huang, Y., Song, X., Zhou, Y., Li, Y., Pei, Q., Tan, Q., & Pei, H. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s108134 · Cited by 12
“21 The present study suggested that ZNRF3 might function as a tumor suppressor via the suppression of Wnt/ β -catenin/TCF pathway in colorectal cancer.”
Mancini, M., Castagnetti, F., Soverini, S., Leo, E., Benedittis, C. D., Gugliotta, G., Rosti, G., Bavaro, L., Santis, S. D., Monaldi, C., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26052 · Cited by 11
“…(BI 2536 belonging to the same family of BI6727 and rigosertib [ON-01910]) have been already advanced for clinical use and found to synergize with TK inhibitors in IM-sensitive and IMresistant CML cells [Jamieson et al.,2004; Gleixner et al., 2010; Okabe et al., 2015; Culen et al., 2016].”
BackgroundKidan, N., Khamaisie, H., Ruimi, N., Roitman, S., Eshel, E., Dally, N., Ruthardt, M., & Mahajna, J. A. (2017) · Journal of Cancer · doi:10.7150/jca.19633 · Cited by 13
“Specifically, granulocytemacrophage progenitors from CML patients and BC cells from patients who are resistant to therapy display activated Wnt signaling [41].”
BackgroundChronic myeloid leukemia stem cells require cell-autonomous pleiotrophin signaling
Himburg, H. A., Roos, M. M., Fang, T., Zhang, Y., Termini, C. M., Schlussel, L., Kim, M., Pang, A., Kan, J., Zhao, L., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129061 · Cited by 12
“restricted to the HSC compartment and granulocyte-macrophage progenitors can acquire CML stem cell properties via stabilization of nuclear beta-catenin (24).”
BackgroundRendering the Leukemia Cell Susceptible to Attack
Sipkins, D. A. (2009) · New England Journal of Medicine · doi:10.1056/nejmcibr0904291 · Cited by 11
BCR-ABL induces opposite phenotypes in murine ES cells according to STAT3 activation levels
Coppo, P., Dusanter‐Fourt, I., Vainchenker, W., & Turhan, A. G. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.09.006 · Cited by 12
Normal and Neoplastic Stem Cells
McCracken, M. N., George, B. M., Kao, K. S., Marjon, K. D., Raveh, T., & Weissman, I. L. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030965 · Cited by 12
“Initial studies for identifying a LSC began with our work on chronic myelogenous leukemia (CML) and acute myeloid leukemia (AML) (Miyamoto et al. 2000; Jamieson et al. 2004a,b; Abrahamsson et al. 2009; Majeti et al. 2009a).”
BackgroundÇalışkan, C., Yüce, Z., & Sercan, H. O. (2022) · Gene · doi:10.1016/j.gene.2022.147109 · Cited by 10
Mammary Cells with Active Wnt Signaling Resist ErbB2-Induced Tumorigenesis
Bu, W., Zhang, X., Dai, H., Huang, S., & Li, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078720 · Cited by 10
Melenhorst, J. J., & Barrett, A. J. (2010) · Cytotherapy · doi:10.3109/14653249.2010.530649 · Cited by 11
Bennemann, K., Galm, O., Wilop, S., Schubert, C., Brümmendorf, T. H., & Jost, E. (2012) · Clinical Epigenetics · doi:10.1186/1868-7083-4-12 · Cited by 12
Tracking of Normal and Malignant Progenitor Cell Cycle Transit in a Defined Niche
Pineda, G., Lennon, K. M., Santos, N. P. D., Lambert-Fliszar, F., Riso, G. L., Lazzari, E., Marra, M. A., Morris, S., Sakaue-Sawano, A., Miyawaki, A., et al. (2016) · Scientific Reports · doi:10.1038/srep23885 · Cited by 11
Buchstaller, J., Quintana, E., & Morrison, S. J. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10010-x · Cited by 10
IQGAP1 Scaffold–MAP Kinase Interactions Enhance Multiple Myeloma Clonogenic Growth and Self-Renewal
Gocke, C. B., McMillan, R. H., Wang, Q., Begum, A., Penchev, V. R., Ali, S. A., Borrello, I., Huff, C. A., & Matsui, W. H. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0323 · Cited by 12
“Given these findings, it is possible that RAS/MAPK signaling drives self-renewal in relatively differentiated myeloma progenitors similar to findings in CML (47).”
ResultThe evolution of leukaemia from pre‐leukaemic and leukaemic stem cells
Shlush, L. I., & Feldman, T. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13236 · Cited by 11
Patel, S. A., Bledsoe, J. R., Higgins, A. W., Hutchinson, L., & Gerber, J. M. (2021) · JCO Precision Oncology · doi:10.1200/po.21.00039 · Cited by 10
“The defining molecular abnormality that drives leukemogenesis in CML is BCR-ABL1 fusion gene, resulting from a reciprocal translocation between chromosomes 9 and 22.(1) The breakpoint cluster region on chromosome 22 fuses with the Abelson-1 nonreceptor tyrosine kinase on chromosome 9 to produce a novel oncoprotein.”
BackgroundInfluentialGoldstein, O., Mandujano-Tinoco, E. A., Levy, T., Talice, S., Raveh, T., Gershoni‐Yahalom, O., Voskoboynik, A., & Rosental, B. (2021) · Marine Drugs · doi:10.3390/md19080454 · Cited by 10
Radich, J. P., Wall, M. A., Branford, S., Campbell, C. D., Chaturvedi, S., DeAngelo, D. J., Deininger, M. W., Guinney, J., Hochhaus, A., Hughes, T. P., et al. (2023) · Haematologica · doi:10.3324/haematol.2022.281878 · Cited by 13
Juan, W. C., & Ong, S. T. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-396456-4.00007-9 · Cited by 13
Bone marrow localization and functional properties of human hematopoietic stem cells
Boyd, A. L., & Bhatia, M. (2014) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000055 · Cited by 11
“and CML–LSCs may indicate that they represent caricatures of different levels of the hematopoietic hierarchy, respectively [70,71], as HSCs and hematopoietic progenitor cells are likewise subject to dissociable extrinsic regulation [7 & ,29 && ].”
BackgroundImmunologic targeting of the cancer stem cell
Wu, C. J. (2008) · StemBook · doi:10.3824/stembook.1.21.1 · Cited by 13
“By now, the existence of cancer initiating cells has been demonstrated in many malignancies (Al-Hajj et al., 2003; Bonnet and Dick, 1997; Jamieson et al., 2004; Singh et al., 2003) (Schatton et al., 2008).”
BackgroundInfluentialStem cells in gastrointestinal cancers: a matter of choice in cell fate determination
Wei, B., Chen, L., Li, R., & Tian, J. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.52 · Cited by 10
Manachai, N., Saito, Y., Nakahata, S., Bahirvani, A. G., Osato, M., & Morishita, K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.146 · Cited by 10
“An aberrant activation of the Wnt/b-catenin pathway is a key regulator in CML stem cell maintenance with contribution to the CML disease progression [3,4].”
Understanding the role of asymmetric cell division in cancer using C. elegans
Hyenne, V., Chartier, N. T., & Labbé, J. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22237 · Cited by 12
“Indeed, recent provocative studies point to the need to understand not only the cell of origin of cancer but also the initial molecular events leading to so-called ‘‘pre-tumorigenic stem cells’’ (i.e., clonal evolution; Miyamoto et al., 2000; Jamieson et al., 2004).”
Zhang, Z., Liu, T., & Zhang, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.067 · Cited by 9
Yin, X., Zhou, M., Zhang, L., Fu, Y., Xu, M., Wang, X., Cui, Z., Gao, Z., Li, M., Dong, Y., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05234-5 · Cited by 10
“Thus, differentiation blockage in progenitor stages is the mainstay of BC phase progression [5, 6].”
BackgroundPérez-Caro, M., & Sánchez-García, I. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-200-7_1 · Cited by 10
Beta-Catenin Mutations are not Observed in Chronic Myeloid Leukemia
Sercan, Z., Pehli̇van, M., Göktürk, D., & Sercan, H. O. (2009) · Tumori Journal · doi:10.1177/030089160909500633 · Cited by 9
Evolution of normal and neoplastic tissue stem cells: progress after Robert Hooke
Weissman, I. L. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0364 · Cited by 9
Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function
Xiao, M., Ai, H., Li, T., Rajoria, P., Shahu, P., & Li, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.018 · Cited by 9
Mahdloo, T., Sahami, P., Ramezani, R., Jafarinia, M., Goudarzi, H., & Babashah, S. (2021) · EXCLI journal · doi:10.17179/excli2021_3404 · Cited by 10
Tonc, E., Takeuchi, Y., Chou, C., Xia, Y., Holmgren, M., Fujii, C., Raju, S., Chang, G. S., Iwamoto, M., & Egawa, T. (2021) · Blood · doi:10.1182/blood.2021011711 · Cited by 12
Understanding autophagy role in cancer stem cell development
Aguilar-Gallardo, C., Zamorano, M., Farías, J. G., & Quevedo, K. D. A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07299-z · Cited by 12
Thomas, X. (2012) · World Journal of Stem Cells · doi:10.4252/wjsc.v4.i6.44 · Cited by 9
Mutant CEBPA: Priming Stem Cells for Myeloid Leukemogenesis
Somervaille, T. C. P., & Cleary, M. L. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.10.008 · Cited by 11
“…eventually generate 09 Elsevier Inc. granulocyte-macrophage progenitors (GMPs) with enhanced in vitro proliferative potential in the acute phase (Jamieson et al., 2004), and also AML1-ETO-associated AML, where the fusion oncogene may be found expressed in the HSC compartment for years following…”
Background
Metadata
- Authors
- Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., Sawyers, C. L., & Weissman, I. L.
- Affiliations
- Stanford Medicine (US)
- University of Toronto (CA)
- University of California, Los Angeles (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-08-12
- Volume
- 351
- Issue
- 7
- Pages
- 657-667
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012962381
- Cited by
- 1,485
- References
- 58
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 19 · 2023: 36 · 2022: 27 · 2021: 33 · 2020: 40 · 2019: 37 · 2018: 40 · 2017: 53 · 2016: 80 · 2015: 74 · 2014: 81 · 2013: 95 · 2012: 114
- FWCI
- 55.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23HL04409, K23HL004409)
- National Cancer Institute (2PO1CA49605, CA 86017, CA 55209, R01CA086017, P01CA049605)
- National Institute of Allergy and Infectious Diseases (5 T32 AI07290, T32AI007290)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- chronic myeloid leukemia, blast crisis, leukemia stem cells, CFU-GM, β-catenin signaling, BCR-ABL, self-renewal, Axin, imatinib resistance, hematopoietic stem cells, myeloid progenitor cells
- MeSH terms
- Imatinib Mesylate, Adult, Aged, Antineoplastic Agents, Benzamides, Blast Crisis, Colony-Forming Units Assay, Cytoskeletal Proteins, DNA-Binding Proteins, Female, Granulocytes, Hematopoietic Stem Cells, Humans, Macrophages, Male, Middle Aged, Piperazines, Pyrimidines, RNA, Neoplasm, Transcription Factors, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Trans-Activators, Fusion Proteins, bcr-abl, Microscopy, Confocal, Drug Resistance, Neoplasm, Reverse Transcriptase Polymerase Chain Reaction, beta Catenin, Lymphoid Enhancer-Binding Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.